We are live on
!
Find out more
CS
Candriam SCA Portfolio holdings
AUM
$19.3B
1-Year Est. Return
39.18%
This Fund
S&P 500
This Quarter
Est. Return
-12.38%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$12.1B
AUM Growth
-$2.55B
(-17%)
Cap. Flow
-$469M
Cap. Flow
% of AUM
-3.86%
Top 10 Holdings %
Top 10 Hldgs %
25.18%
Holding
858
New
52
Increased
315
Reduced
272
Closed
83
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$38.7M |
| 2 |
Apple
AAPL
|
+$27.7M |
| 3 |
Salesforce
CRM
|
+$26.1M |
| 4 |
Verizon
VZ
|
+$25.9M |
| 5 |
PepsiCo
PEP
|
+$24.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$65.7M |
| 2 |
Waste Management
WM
|
+$64.8M |
| 3 |
Sociedad Química y Minera de Chile
SQM
|
+$58.6M |
| 4 |
Citigroup
C
|
+$56.5M |
| 5 |
Johnson & Johnson
JNJ
|
+$41M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 34.24% |
| 2 | Technology | 24.24% |
| 3 | Financials | 8.36% |
| 4 | Communication Services | 6.82% |
| 5 | Industrials | 6.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Elevance Health
ELV
$81.9B
| $28.4M | 0.23% |
58,818
+3,661
| +7% | +$1.81M |
|
102
Tetra Tech
TTEK
$8.23B
| $28.2M | 0.23% |
1,031,700
+88,880
| +9% | +$2.44M |
|
103
ConocoPhillips
COP
$147B
| $28.2M | 0.23% |
313,609
+40,575
| +15% | +$4.18M |
|
|
APLS
104
DELISTED
Apellis Pharmaceuticals
APLS
| $27.8M | 0.23% |
615,457
+149,362
| +32% | +$6.81M |
|
105
Advanced Drainage Systems
WMS
$10.9B
| $27.6M | 0.23% |
306,533
-50,794
| -14% | -$5.22M |
|
106
3M
MMM
$89B
| $26.7M | 0.22% |
246,958
+3,999
| +2% | +$483K |
|
107
Automatic Data Processing
ADP
$100B
| $26.6M | 0.22% |
126,555
-12,869
| -9% | -$2.82M |
|
108
Xenon Pharmaceuticals
XENE
$6.32B
| $26.3M | 0.22% |
863,140
+258,886
| +43% | +$7.83M |
|
109
Bruker
BRKR
$9.2B
| $25.9M | 0.21% |
413,186
+154,157
| +60% | +$9.45M |
|
110
CrowdStrike
CRWD
$187B
| $25.8M | 0.21% |
612,748
-84,804
| -12% | -$3.84M |
|
111
Texas Instruments
TXN
$255B
| $25.6M | 0.21% |
166,877
-124,575
| -43% | -$21M |
|
112
Universal Display
OLED
$3.71B
| $25.6M | 0.21% |
253,436
+39,728
| +19% | +$5.11M |
|
113
Halozyme
HALO
$9.72B
| $25.6M | 0.21% |
582,497
-122,509
| -17% | -$5.3M |
|
114
SolarEdge
SEDG
$2.59B
| $25.6M | 0.21% |
93,615
+15,612
| +20% | +$4.27M |
|
115
Berkshire Hathaway Class B
BRK.B
$1.07T
| $25.2M | 0.21% |
92,224
-20,389
| -18% | -$6.4M |
|
116
HCA Healthcare
HCA
$84.8B
| $25M | 0.21% |
148,562
+37,923
| +34% | +$8.15M |
|
|
GBT
117
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $24.9M | 0.21% |
779,691
+22,983
| +3% | +$673K |
|
118
Xencor
XNCR
$1.44B
| $24.9M | 0.21% |
909,699
+32,718
| +4% | +$807K |
|
119
Cadence Design Systems
CDNS
$90B
| $24.8M | 0.2% |
165,149
+30,716
| +23% | +$4.64M |
|
120
AutoZone
AZO
$48.3B
| $24.6M | 0.2% |
11,464
+9,979
| +672% | +$20.5M |
|
121
Invitation Homes
INVH
$17.7B
| $24.6M | 0.2% |
690,451
+18,744
| +3% | +$715K |
|
122
Target
TGT
$62.1B
| $24.4M | 0.2% |
173,026
+23,664
| +16% | +$4.54M |
|
123
Keysight
KEYS
$54.5B
| $24.2M | 0.2% |
175,336
-29,145
| -14% | -$4.15M |
|
|
IPG
124
DELISTED
Interpublic Group of Companies
IPG
| $23.9M | 0.2% |
868,303
-3,160
| -0.4% | -$100K |
|
125
Enphase Energy
ENPH
$4.84B
| $23.7M | 0.2% |
121,484
-48,194
| -28% | -$8.71M |
|
Similar funds
PCM
A
MGP
LF
SOMRS
BPA
MIM
Candriam SCA's Q2 2022 Portfolio in Review
As of Q2 2022, Candriam SCA held 858 positions worth $12.1B, down 17% from $14.7B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Candriam SCA withdrew a net $469M in Q2 2022, closing 83 positions and reducing 272 holdings. Its most notable exit was TriState Capital Holdings, Inc., an estimated $20.9M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 29% a quarter earlier, followed by Technology and Financials.
Against the trend, Candriam SCA opened a new position in Tenable Holdings worth $16.3M.
- Candriam SCA's largest Q2 2022 buy was Tenable Holdings: 359,981 shares worth $16.3M.
- Candriam SCA added most to Procter & Gamble in Q2 2022, an estimated $38.7M increase.
- Candriam SCA's biggest Q2 2022 reduction was Microsoft, cutting an estimated $65.7M.
- Candriam SCA fully exited TriState Capital Holdings, Inc. in Q2 2022, selling an estimated $20.9M.
- Candriam SCA's ten largest holdings make up 25% of its $12.1B portfolio in Q2 2022.
- Candriam SCA opened 52 new positions and closed 83 in Q2 2022.
- Candriam SCA's portfolio value fell 17% quarter-over-quarter to $12.1B.
Based on Candriam SCA's 13F filing for Q2 2022, filed 3 Aug 2022.